Themis Medicare Limited — Board Meeting, 01-08-2025: Outcome of Board Meeting

Themis Medicare's board meeting saw key strategic shifts. The company reported a consolidated net loss of ₹14.22 Cr on ₹97.57 Cr revenue for the quarter ended June 30. A final dividend for FY25 was approved, with September 5 as the record date. Crucially, the board withdrew the proposed merger with Gujarat Themis Biosyn, deciding to sharpen focus on its core domestic formulations business for long-term growth. Additionally, Ms. Neha Thakore was appointed as an Independent Director and Mr. Viraj Save as Executive President, Sales & Marketing.